Morikawa Hiromasa

モリカワヒロマサ | Morikawa Hiromasa

Affiliation and department：
Job title：診療部長
Homepage URL (1)： https://www.linkedin.com/in/hmorikawa/

Research field (3)： Genomics , Respiratory surgery , Immunology

Research theme for competitive and other funds (4)：

2016 - 2017 Single cell regulatory genomic networks on human CD4+ T-cells
2015 - 2017 An integrative computational-experimental method resolving single cell regulatory genomic networks.
2014 - 2015 1細胞単位の解析に必要な技術の開発とその臨床応用
2014 - 2015 ヒト免疫細胞における1細胞単位のRNA測定技術、タンパク測定技術、解析技術の開発とその臨床応用

Papers (41)：

Atsushi Tanaka, Shinji Maeda, Takashi Nomura, Mara Anais Llamas-Covarrubias, Satoshi Tanaka, Lin Jin, Ee Lyn Lim, Hiromasa Morikawa, Yohko Kitagawa, Shuji Akizuki, et al. Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease. The Journal of experimental medicine. 2023. 220. 2
Masahide Isowa, Reo Hamaguchi, Ryoko Narui, Hiromasa Morikawa, Hiromi Wada. Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study. Frontiers in oncology. 2023. 13. 1179049-1179049
Masahide Isowa, Reo Hamaguchi, Ryoko Narui, Hiromasa Morikawa, Hiromi Wada. Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study. Frontiers in oncology. 2023. 13. 1291026-1291026
Grapotte, M., Saraswat, M., Bessi{\`e}re, C., Menichelli, C., Ramilowski, J.A., Severin, J., Hayashizaki, Y., Itoh, M., Tagami, M., Murata, M., et al. Author Correction: Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network (Nature Communications, (2021), 12, 1, (3297), 10.1038/s41467-021-23143-7). Nature Communications. 2022. 13. 1
Hiromi Wada, Reo Hamaguchi, Ryoko Narui, Hiromasa Morikawa. Meaning and Significance of "Alkalization Therapy for Cancer". Frontiers in oncology. 2022. 12. 920843-920843

ｍore...

MISC (66)：

Ewoud Ewing, Sabrina Ruhrmann, Lara Kular, Yun Liu, Sunjay Fernandes, Hiromasa Morikawa, Jesper Tegner, Nestoras Karanthanasis, Vincenzo Lagani, Ioannis Tsamardinos, et al. Shared DNA methylation profiles in four immune cell types from Multiple Sclerosis patients. SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017. 86. 4. 282-282
Masahide Hamaguchi, Naganari Ohkura, Hiromasa Morikawa, Kyoko Sugimura, Atsushi Tanaka, Yoshinaga Ito, Motonao Osaki, Yoshiaki Tanaka, Riu Yamashita, Naoko Nakano, et al. Concurrent epigenetic conversion and Foxp3 expression have \ncomplementary roles in the development of regulatory T cells. Joint Symposium of Seoul St. Mary’s Hop, Osaka Univ. Postech.(2011. 12. 19. Seoul, Korea). 2011
山田徹, 園部誠, 木曾末厘乃, 森川洋匡, 陳豊史, 佐藤澄, 藤永卓司, 庄司剛, 阪井宏彰, 宮原亮, et al. WS2-5 肺大細胞神経内分泌癌手術例の検討(神経内分泌細胞癌の診断と治療,第49回日本肺癌学会総会号). 肺癌. 2008. 48. 5. 418-418
園部誠, 森川洋匡, 山田徹, 陳豊史, 藤永卓司, 庄司剛, 佐藤澄, 阪井宏彰, 宮原亮, 大久保憲一, et al. WS6-5 病理病期II期,III期非小細胞肺癌に対する術後補助療法としてのCDDP/VNR併用療法(原発性肺癌に対する術前・術後治療の現状と展望,第49回日本肺癌学会総会号). 肺癌. 2008. 48. 5. 424-424
庄司剛, 山田徹, 森川洋匡, 陳豊史, 藤永卓司, 佐藤澄, 園部誠, 阪井宏彰, 宮原亮, 板東徹, et al. WS8-3 浸潤型胸腺種に対する集学的治療(胸腺腫の集学的治療,第49回日本肺癌学会総会号). 肺癌. 2008. 48. 5. 427-427

ｍore...

Patents (1)：

間質性肺炎の治療剤

Books (3)：

膵島の再生医療(再生医療シリーズ)
医学書出版 2015
日本移植学会 50 周年記念誌
日本移植学会50周年記念誌編集委員会編, 日本移植学会 2014
制御性T細胞 -その基礎と臨床展開
医歯薬出版 2013

Professional career (3)：

M.D. (京都大学医学部医学科)
Ph.D. (京都大学大学院医学研究科)
M.B.A. (グロービス経営大学院)

Work history (11)：

2019/04 - 現在 Tanaka clinic
2017/09 - 2019/04 King Abdullah University of Science and Technology Living Systems Laboratory Research Consultant
2018/04 - 2019/03 Institute for Frontier Life and Medical Sciences, Kyoto University Part time lecturer
2017/09 - 2019/03 AstraZeneca Medical Affairs, Immuno-Oncology Science Lead
2015/01 - 2018/08 Karolinska Institutet Center for Molecular Medicine - CMM Vinnmer-Marie Curie Fellow

Show all

Committee career (1)：

2011/10 - 2021/10 The Japanese Association for Chest Surgery Councilor

Association Membership(s) (4)：

Japanese Association for Medical Artificial Intelligence , 一般社団法人日本在宅医療連合学会 , THE JAPANESE ASSOCIATION FOR THORACIC SURGERY , JAPAN SURGICAL SOCIETY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page